AU2002231811B2 - Use of flumazenil to produce a medicament for the treatment of cocaine dependency - Google Patents

Use of flumazenil to produce a medicament for the treatment of cocaine dependency Download PDF

Info

Publication number
AU2002231811B2
AU2002231811B2 AU2002231811A AU2002231811A AU2002231811B2 AU 2002231811 B2 AU2002231811 B2 AU 2002231811B2 AU 2002231811 A AU2002231811 A AU 2002231811A AU 2002231811 A AU2002231811 A AU 2002231811A AU 2002231811 B2 AU2002231811 B2 AU 2002231811B2
Authority
AU
Australia
Prior art keywords
flumazenil
medicament
treatment
cocaine
administrable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002231811A
Other languages
English (en)
Other versions
AU2002231811A1 (en
Inventor
Juan Jose Legarda Ibanez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catasys Inc
Original Assignee
Catasys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catasys Inc filed Critical Catasys Inc
Publication of AU2002231811A1 publication Critical patent/AU2002231811A1/en
Application granted granted Critical
Publication of AU2002231811B2 publication Critical patent/AU2002231811B2/en
Priority to AU2006200922A priority Critical patent/AU2006200922A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
AU2002231811A 2001-02-15 2002-02-08 Use of flumazenil to produce a medicament for the treatment of cocaine dependency Ceased AU2002231811B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2006200922A AU2006200922A1 (en) 2001-02-15 2006-03-03 Use of flumazenil to produce a medicament for the treatment of cocaine dependency

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200100342 2001-02-15
ESP200100342 2001-02-15
PCT/ES2002/000061 WO2002064213A1 (es) 2001-02-15 2002-02-08 Empleo de flumazenilo en la elaboracion de un medicamento para el tratamiento de la dependencia de cocaina

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2006200922A Division AU2006200922A1 (en) 2001-02-15 2006-03-03 Use of flumazenil to produce a medicament for the treatment of cocaine dependency

Publications (2)

Publication Number Publication Date
AU2002231811A1 AU2002231811A1 (en) 2003-02-20
AU2002231811B2 true AU2002231811B2 (en) 2006-02-16

Family

ID=8496743

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002231811A Ceased AU2002231811B2 (en) 2001-02-15 2002-02-08 Use of flumazenil to produce a medicament for the treatment of cocaine dependency

Country Status (20)

Country Link
US (2) US7186711B2 (https=)
EP (1) EP1378267B1 (https=)
JP (2) JP4272885B2 (https=)
KR (1) KR100712571B1 (https=)
CN (1) CN1327843C (https=)
AT (1) ATE363923T1 (https=)
AU (1) AU2002231811B2 (https=)
BR (1) BR0207866A (https=)
CA (1) CA2436511C (https=)
CY (1) CY1106845T1 (https=)
DE (1) DE60220512T2 (https=)
DK (1) DK1378267T3 (https=)
ES (1) ES2287255T3 (https=)
IL (1) IL157144A0 (https=)
MX (1) MXPA03007281A (https=)
NZ (1) NZ528164A (https=)
PT (1) PT1378267E (https=)
RU (1) RU2322985C2 (https=)
UA (1) UA79586C2 (https=)
WO (1) WO2002064213A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192271A1 (en) * 2003-07-15 2005-09-01 Hythiam, Inc. Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse
CA2436511C (en) * 2001-02-15 2009-08-04 Juan Jose Legarda Ibanez Use of flumazenil to produce a medicament for the treatment of cocaine dependency
JP2008538748A (ja) 2005-04-07 2008-11-06 ハイシアム， インコーポレイテッド 不安、物質乱用及び依存の予防のための改良型方法及び組成物
US7855196B2 (en) 2005-08-22 2010-12-21 Pierre Mainville Composition comprising a benzodiazepine agonist and a benzodiazepine antagonist
ES2289935B1 (es) * 2006-07-14 2008-12-16 Juan Jose Legarda Ibañez Empleo de flumazenilo en la elaboracion de un medicamento para el tratamiento de la patologia depresiva.
US20110034442A1 (en) * 2007-08-08 2011-02-10 Jaun Jose Legarda Ibanez Use and Methods of Use for an Antagonist of the Serotin3 Receptor (5-HT3) and a Selective Modulator of Chloride Channels for the Treatment of Addiction to or Dependence on Medicines/Drugs or Nervous System Disorders
US9396280B2 (en) * 2008-06-23 2016-07-19 Microsoft Technology Licensing, Llc Command driven web site browsing
ES2702848T3 (es) 2011-02-23 2019-03-05 Coeruleus Ltd Complejos de flumazenil, composiciones que los comprenden y usos de los mismos
US9308616B2 (en) 2013-01-21 2016-04-12 Innovative Finishes LLC Refurbished component, electronic device including the same, and method of refurbishing a component of an electronic device
WO2015054730A1 (en) * 2013-10-14 2015-04-23 Palmaya Pty Ltd Compositions and methods of administering same
CN107115359A (zh) * 2016-02-24 2017-09-01 郑恩哲 阻断海洛因或吗啡毒品中毒路径的点滴处方及其应用
EP3661500B1 (en) 2017-07-31 2026-01-07 Novartis AG Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028611A (en) * 1989-06-29 1991-07-02 The Regents Of The University Of Minnesota Treatment for cocaine use
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use
US5229120A (en) * 1992-02-05 1993-07-20 Devincent James F Treatment for cocaine abuse
GB9225859D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
GB9420010D0 (en) 1994-10-01 1994-11-16 Marck Sharp & Dohme Limited Nucleic acids
EP1133299A1 (en) * 1998-11-23 2001-09-19 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
EP1125579A3 (en) * 2000-01-18 2003-01-02 Pfizer Products Inc. Uses of agrp-melanocortin receptor binding modulating compounds
CA2436511C (en) 2001-02-15 2009-08-04 Juan Jose Legarda Ibanez Use of flumazenil to produce a medicament for the treatment of cocaine dependency
US6740677B2 (en) 2002-08-19 2004-05-25 Hong Xue Methods of treating benzodiazepine site (BZD-S) associated syndromes using 2′ hydroxyflavonoids

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Derlet et al. Neuropharmacology Vol.29(3) (1990) pp 255-259 *
Derwent CAPlus abstract no. 1994:595617 Uki et al. *

Also Published As

Publication number Publication date
KR100712571B1 (ko) 2007-05-02
HK1061817A1 (en) 2004-10-08
EP1378267B1 (en) 2007-06-06
PT1378267E (pt) 2007-09-11
NZ528164A (en) 2006-03-31
ATE363923T1 (de) 2007-06-15
US20070142364A1 (en) 2007-06-21
DE60220512T2 (de) 2008-02-07
WO2002064213A1 (es) 2002-08-22
DK1378267T3 (da) 2007-10-08
JP2008201799A (ja) 2008-09-04
MXPA03007281A (es) 2005-01-25
DE60220512D1 (de) 2007-07-19
JP4272885B2 (ja) 2009-06-03
KR20040010592A (ko) 2004-01-31
CN1491125A (zh) 2004-04-21
CA2436511A1 (en) 2002-08-22
RU2322985C2 (ru) 2008-04-27
US20060122219A1 (en) 2006-06-08
IL157144A0 (en) 2004-02-08
RU2003127718A (ru) 2005-01-27
US7186711B2 (en) 2007-03-06
EP1378267A1 (en) 2004-01-07
BR0207866A (pt) 2004-03-23
CN1327843C (zh) 2007-07-25
JP2004521904A (ja) 2004-07-22
CY1106845T1 (el) 2012-05-23
UA79586C2 (en) 2007-07-10
ES2287255T3 (es) 2007-12-16
CA2436511C (en) 2009-08-04

Similar Documents

Publication Publication Date Title
JP2008201799A (ja) コカイン依存症治療用薬剤
US20080132492A1 (en) Use of Flumazenil in the Production of a Drug for the Treatment of Alcohol Dependency
KR20080004581A (ko) 불안 관련 장애의 치료 방법
JP2004519461A5 (https=)
JP2004521904A5 (https=)
AU2006200922A1 (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
HK1061817B (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
Ganzberg et al. Zaleplon (Sonata) oral sedation for outpatient third molar extraction surgery
KR20080004615A (ko) 알코올 및/또는 흥분성 물질 남용의 치료를 위한 선택적클로라이드 채널 조절제의 용도
AU2006246490B8 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
RU2134106C1 (ru) Способ нормализации толерантности организма к веществу
HK1061661B (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired